Ablation for atrial fibrillation
One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation
Clinical Electrophysiology Unit, Department of Cardiology, Thoraxcentre, Erasmus Medical Centre, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
Aims: Pulmonary vein isolation (PVI) with cryoenergy delivered through a balloon is a new approach in the treatment of atrial fibrillation (AF), but long-term follow-up is lacking. The aim of this study was to provide insight in the success rate and the incidence of recurrences.
Methods and results: Patients with symptomatic AF despite anti-arrhythmic drugs (AADs) were treated with cryoballoon PVI. Daily transtelephonic ECG monitoring, 24 h Holter-ECG, and an arrhythmia-focused questionnaire were used to document AF. One hundred and forty-one patients completed a follow-up of 457 ± 252 days. Before ablation, Holter-ECG showed AF in 45%, including 16% continuous AF throughout the recording. Event recording revealed a median AF burden of 26%. The questionnaire showed a median of weekly AF complaints lasting for hours. All but one patient had successful PVI with a single procedure. After ablation, AF (defined as lasting for more than 30 s) was seen in 11% of Holter-ECGs, with 1% continuous AF. The event recording showed an AF burden of 9%. The median patient reported no more AF-related symptoms. Recurrence during the first 3 months was predictive for later recurrence. A second procedure was performed in 24 patients. The freedom of AF was 59% without AADs after 1,2 procedures. Four right phrenic nerve paralyses occurred, all resolving within 6 months. No PV stenoses were observed.
Conclusion: Pulmonary vein isolation with a cryothermal balloon is an effective treatment for paroxysmal AF, resulting in a clinical success rate comparable to studies involving radiofrequency ablation. Temporary right phrenic nerve paralysis is the most important complication.
Key Words: Ablation, Atrial fibrillation, Cryoablation, Cryoballoon, Follow-up
* Corresponding author. Tel: +31107033991; fax: +31107034420. E-mail address: y.vanbelle{at}erasmusmc.nl
Manuscript submitted 3 June 2008. Accepted after revision 1 August 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Europace:
- Balloon cryoablation for paroxysmal atrial fibrillation
- Rukshen Weerasooriya, Pierre Jais, Meleze Hocini, Frederic Sacher, and Michel Haissaguerre
Europace 2008 10: 1251-1252.[FREE Full Text]
This article has been cited by other articles:
![]() |
H. Bastani, P. Insulander, J. Schwieler, F. Tabrizi, F. Braunschweig, G. Kenneback, N. Drca, B. Sadigh, and M. Jensen-Urstad Safety and efficacy of cryoablation of atrial tachycardia with high risk of ablation-related injuries Europace, May 1, 2009; 11(5): 625 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Van Belle and L. Jordaens Reflections on reconduction after pulmonary vein isolation Europace, April 1, 2009; 11(4): 400 - 401. [Full Text] [PDF] |
||||
![]() |
R. Weerasooriya, P. Jais, M. Hocini, F. Sacher, and M. Haissaguerre Balloon cryoablation for paroxysmal atrial fibrillation Europace, November 1, 2008; 10(11): 1251 - 1252. [Full Text] [PDF] |
||||
